aldosterone has been researched along with indole-3-carbinol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brooker, G; Fleming, S; Kantachuvesiri, S; Kotelevtsev, Y; Lammie, AG; McGrath, I; Mullins, JJ; Peters, B; Peters, J | 1 |
Becher, B; Grisk, O; Kuttler, B; Lorenz, G; Lüdemann, J; Mullins, JJ; Peters, B; Peters, J; Rettig, R; Wanka, H | 1 |
Bürgelová, M; Cervenka, L; Erbanová, M; Husková, Z; Kramer, HJ; Mullins, JJ; Rakusan, D; Thumová, M; Vanecková, I; Vanourková, Z | 1 |
Beineke, A; Hosten, N; Maschke, U; Mullins, JJ; Peters, BS; Peters, J; Rettig, R; Riegel, T; Schlüter, T | 1 |
Clemetson, KJ; Gebhard, S; Gesell-Salazar, M; Greinacher, A; Hammer, E; Kuttler, B; Peters, B; Peters, J; Rettig, R; Scharf, C; Steil, L; Völker, U | 1 |
5 other study(ies) available for aldosterone and indole-3-carbinol
Article | Year |
---|---|
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Precursors; Hypertension; In Situ Hybridization; Indoles; Kidney; Kinetics; Mice; Pedigree; Peptidyl-Dipeptidase A; Precipitin Tests; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Renin; Time Factors; Transcription, Genetic; Transgenes | 2001 |
Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis.
Topics: Administration, Oral; Aldosterone; Animals; Animals, Genetically Modified; Blood Pressure; Cytochrome P-450 CYP1A1; Disease Models, Animal; Dose-Response Relationship, Drug; Glomerulosclerosis, Focal Segmental; Indoles; Kidney; Male; Mice; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Renin; Time; Titrimetry | 2008 |
Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Hypertension; Indoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renal Circulation; Renin; Renin-Angiotensin System; Sodium; Time Factors | 2009 |
Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.
Topics: Administration, Oral; Aldosterone; Animals; Cardiomegaly; Collagen Type I; Cytochrome P-450 CYP1A1; Disease Models, Animal; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hyperaldosteronism; Hypertension; Indoles; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Membrane Glycoproteins; Mice; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Rats, Transgenic; Renin; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 2009 |
Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Platelets; Humans; Hypertension; Indoles; Male; Mass Spectrometry; Proteome; Proteomics; Rats; Rats, Inbred F344; Renin; Risk Factors | 2011 |